Overview

Recent News

Date	Title and Summary
Toggle Summary Mar 04, 2013	Trading of Depomed Common Stock Halted Advisory Committee of the Food and Drug Administration to Discuss SEFELSA™ New Drug Application for the Treatment of Moderate to Severe Vasomotor Symptoms Conference Call Later Today NEWARK, Calif. , March 4, 2013 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) announced that NASDAQ has halted trading
Toggle Summary Oct 11, 2010	THE MICHAEL J. FOX FOUNDATION AWARDS DEPOMED A SECOND DEVELOPMENT GRANT IN PARKINSON'S DISEASE MENLO PARK, Calif. - October 11, 2010 - Depomed, Inc. (NASDAQ:DEPO) announced today that it has been awarded a clinical grant by The Michael J. Fox Foundation under its Clinical Intervention Awards 2010 program. The modest grant amount supports Depomed in the development of a gastric retentive
Toggle Summary Jul 23, 2008	The Michael J. Fox Foundation Awards Depomed a Preclinical Development Grant for Levodopa/Carbidopa in Parkinson's Disease MENLO PARK, Calif.--(BUSINESS WIRE)--July 23, 2008--Depomed, Inc. (NASDAQ:DEPO) announced today that it has been awarded a preclinical grant by The Michael J. Fox Foundation under the foundation's Therapeutics Development Initiative 2008 Program. The modest grant amount supports Depomed in the

Date	Event Details	Remind Me
May 11, 2021 at 1:00 PM CDT	Annual Meeting of Stockholders Click here for webcast	Add to Outlook Add to Google Calendar

Filing date	Description	Form	Filing Group	View
Apr 12, 2021	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	Proxy Filings	View HTML 0001104659-21-049340.pdf 0001104659-21-049340.rtf 0001104659-21-049340.xls
Apr 02, 2021	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001104659-21-046066.pdf 0001104659-21-046066.rtf 0001104659-21-046066.xls
Mar 23, 2021	Report of unscheduled material events or corporate event	8-K	Current Reports	View HTML 0001104659-21-040378.pdf 0001104659-21-040378.rtf 0001104659-21-040378.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 22, 2021	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	View HTML 0001808665-21-000030.pdf 0001808665-21-000030.rtf 0001808665-21-000030.xls
Mar 22, 2021	Initial filing by director officer or owner of more than ten percent.	3	3,4,5	View HTML 0001808665-21-000031.pdf 0001808665-21-000031.rtf 0001808665-21-000031.xls

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
Phone: 800.509.5586
http://www.continentalstock.com

Grant Thornton LLP
Chicago, IL

Max Nemmers
Head, Investor Relations and Administration
investor@assertiotx.com